Treatment of Severe Asthma: Case Report of Fast Action of Mepolizumab in a Patient with Recent SARS-CoV-2 Infection
Abstract
:1. Introduction
1.1. COVID-19 and Pediatric Asthma
1.2. Management and Treatment of Severe Asthma
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Asthma Statistics|AAAAI [Internet]. Available online: https://www.aaaai.org/about/news/for-media/asthma-statistics (accessed on 25 July 2024).
- 2024 GINA Main Report—Global Initiative for Asthma—GINA [Internet]. Available online: https://ginasthma.org/2024-report/ (accessed on 25 July 2024).
- Senter, J.P.; Aisenberg, L.K.; Dudley, J.W.; Luan, X.; Huang, J.; Kenyon, C.C.; Hill, D.A. COVID-19 and Asthma Onset in Children. Pediatrics 2024, 153, e2023064615. [Google Scholar] [CrossRef] [PubMed]
- Jartti, T.; Gern, J.E. Role of viral infections in the development and exacerbation of asthma in children. J. Allergy Clin. Immunol. 2017, 140, 895–906. Available online: https://pubmed.ncbi.nlm.nih.gov/28987219/ (accessed on 25 July 2024). [CrossRef] [PubMed]
- Liu, L.; Pan, Y.; Zhu, Y.; Song, Y.; Su, X.; Yang, L.; Li, M. Association between rhinovirus wheezing illness and the development of childhood asthma: A meta-analysis. BMJ Open 2017, 7, e013034. Available online: https://pubmed.ncbi.nlm.nih.gov/28373249/ (accessed on 25 July 2024). [CrossRef] [PubMed]
- Corne, J.M.; Marshall, C.; Smith, S.; Schreiber, J.; Sanderson, G.; Holgate, S.T.; Johnston, S.L. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: A longitudinal cohort study. Lancet 2002, 359, 831–834. Available online: https://pubmed.ncbi.nlm.nih.gov/11897281/ (accessed on 25 July 2024). [CrossRef]
- Venkatesan, P. 2023 GINA report for asthma. Lancet Respir. Med. 2023, 11, 589. Available online: https://pubmed.ncbi.nlm.nih.gov/37302397/ (accessed on 25 July 2024). [CrossRef] [PubMed]
- Zhang, L.; Liu, H.; Ai, T.; Chen, Z.; Tang, W.; Hu, S.; Hu, J. Epidemiology of asthma exacerbation in children before and after the COVID-19 pandemic: A retrospective study in Chengdu, China. BMC Pediatr. 2023, 23, 588. Available online: https://pubmed.ncbi.nlm.nih.gov/37993873/ (accessed on 25 July 2024). [CrossRef]
- Chung, K.F.; Wenzel, S.E.; Brozek, J.L.; Bush, A.; Castro, M.; Sterk, P.J.; Adcock, I.M.; Bateman, E.D.; Bel, E.H.; Bleecker, E.R.; et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur. Respir. J. 2014, 43, 343–373. Available online: https://pubmed.ncbi.nlm.nih.gov/24337046/ (accessed on 25 July 2024). [CrossRef]
- Robbins, E.; Daoud, S.; Demissie, S.; James, P. The impact of asthma on COVID-19 disease severity in children and adolescents. J. Asthma 2023, 60, 1097–1103. Available online: https://pubmed.ncbi.nlm.nih.gov/36200730/ (accessed on 25 July 2024). [CrossRef]
- Cui, X.; Zhao, Z.; Zhang, T.; Guo, W.; Guo, W.; Zheng, J.; Zhang, J.; Dong, C.; Na, R.; Zheng, L.; et al. A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19). J. Med. Virol. 2021, 93, 1057–1069. Available online: https://pubmed.ncbi.nlm.nih.gov/32761898/ (accessed on 25 July 2024). [CrossRef]
- Klain, A.; Indolfi, C.; Dinardo, G.; Decimo, F.; Miraglia Del Giudice, M. COVID-19 and spirometry in this age. Ital. J. Pediatr. 2022, 48, 11. Available online: https://ijponline.biomedcentral.com/articles/10.1186/s13052-022-01199-5 (accessed on 25 July 2024). [CrossRef]
- Indolfi, C.; Izzo, L.F.; Luciano, M.; Mercogliano, M.; Klain, A.; Dinardo, G.; Decimo, F.; Giudice, M.M. Impact of reduced COVID-19 restrictions on pediatric recurrent respiratory infections in Southern Italy: A cross-sectional analysis. Open Explor. 2024, 2, 340–349. Available online: https://www.explorationpub.com/Journals/eaa/Article/100949 (accessed on 25 July 2024). [CrossRef]
- Pellegrino, R.; Chiappini, E.; Licari, A.; Galli, L.; Marseglia, G.L. Prevalence and clinical presentation of long COVID in children: A systematic review. Eur. J. Pediatr. 2022, 181, 3995. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Esposito, S.; Principi, N.; Azzari, C.; Cardinale, F.; Di Mauro, G.; Galli, L.; Gattinara, G.C.; Fainardi, V.; Guarino, A.; Lancella, L.; et al. Italian intersociety consensus on management of long covid in children. Ital. J. Pediatr. 2022, 48, 42. Available online: https://pubmed.ncbi.nlm.nih.gov/35264214/ (accessed on 25 July 2024). [CrossRef]
- Parisi, G.F.; Diaferio, L.; Brindisi, G.; Indolfi, C.; Umano, G.R.; Klain, A.; Marchese, G.; Ghiglioni, D.G.; Zicari, A.M.; Marseglia, G.L.; et al. Cross-Sectional Survey on Long Term Sequelae of Pediatric COVID-19 among Italian Pediatricians. Children 2021, 8, 769. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Umano, G.R.; Rondinelli, G.; Rivetti, G.; Klain, A.; Aiello, F.; Miraglia del Giudice, M.; Decimo, F.; Papparella, A.; Miraglia del Giudice, E. Effect of COVID-19 Lockdown on Children’s Eating Behaviours: A Longitudinal Study. Children 2022, 9, 1078. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Rahman, N.H.A.; Mohd Zahir, M.Z.; Althabhawi, N.M. Repercussions of COVID-19 Lockdown on Implementation of Children’s Rights to Education. Children 2023, 10, 474. Available online: https://pubmed.ncbi.nlm.nih.gov/36980031/ (accessed on 25 July 2024). [CrossRef]
- Miraglia del Giudice, M.; Klain, A.; Dinardo, G.; D’Addio, E.; Bencivenga, C.L.; Fontanella, C.; Decimo, F.; Umano, G.R.; Siciliano, M.; Carotenuto, M.; et al. Behavioral and Sleep Disorders in Children and Adolescents following COVID-19 Disease: A Case-Control Study. Children 2023, 10, 1189. Available online: https://www.mdpi.com/2227-9067/10/7/1189/htm (accessed on 25 July 2024). [CrossRef] [PubMed]
- Zhang, J.; Dong, X.; Liu, G.; Gao, Y. Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality. Clin. Rev. Allergy Immunol. 2022, 64, 90–107. Available online: https://link.springer.com/article/10.1007/s12016-022-08921-5 (accessed on 25 July 2024). [CrossRef] [PubMed]
- Brindisi, G.; Zicari, A.M.; Parisi, G.F.; Diaferio, L.; Indolfi, C.; Marchese, G.; Ghiglioni, D.G.; Umano, G.R.; Klain, A.; Marseglia, G.L.; et al. Prevalence of COVID-19 in children affected by allergic rhinoconjunctivitis and asthma: Results from the second “SIAIP rhinosinusitis and conjunctivitis committee” survey. Ital. J. Pediatr. 2022, 48, 1. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Graff, K.; Smith, C.; Silveira, L.; Jung, S.; Curran-Hays, S.; Jarjour, J.; Carpenter, L.; Pickard, K.; Mattiucci, M.; Fresia, J.; et al. Risk Factors for Severe COVID-19 in Children. Pediatr. Infect. Dis. J. 2021, 40, E137–E145. Available online: https://pubmed.ncbi.nlm.nih.gov/33538539/ (accessed on 25 July 2024). [CrossRef]
- Kara, A.A.; Böncüoğlu, E.; Kıymet, E.; Arıkan, K.; Şahinkaya, Ş.; Düzgöl, M.; Cem, E.; Çelebi, M.; Ağın, H.; Bayram, S.N.; et al. Evaluation of predictors of severe-moderate COVID-19 infections at children: A review of 292 children. J. Med. Virol. 2021, 93, 6634. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Mendes, N.F.; Jara, C.P.; Mansour, E.; Araújo, E.P.; Velloso, L.A. Asthma and COVID-19: A systematic review. Allergy Asthma Clin. Immunol. 2021, 17, 5. Available online: https://pubmed.ncbi.nlm.nih.gov/33407838/ (accessed on 25 July 2024). [CrossRef] [PubMed]
- Nazif, J.; Silver, E.; Okada, C.; Gross, E. Comparison of Children Hospitalized for Asthma Before and During the COVID-19 Pandemic. Pediatr. Allergy Immunol. Pulmonol. 2022, 35, 174–178. Available online: https://pubmed.ncbi.nlm.nih.gov/36537703/ (accessed on 25 July 2024). [CrossRef] [PubMed]
- Indolfi, C.; Klain, A.; Dinardo, G.; D’Addio, E.; Ferrara, S.; Decimo, F.; Ciprandi, G.; Tosca, M.A.; Miraglia del Giudice, M. COVID-19 Pediatric Follow-Up: Respiratory Long COVID-Associated Comorbidities and Lung Ultrasound Alterations in a Cohort of Italian Children. Children 2024, 11, 166. Available online: https://www.mdpi.com/2227-9067/11/2/166/htm (accessed on 25 July 2024). [CrossRef]
- Ahmed, H.; Turner, S. Severe asthma in children-a review of definitions, epidemiology, and treatment options in 2019. Pediatr Pulmonol 2019, 54, 778–787. Available online: https://pubmed.ncbi.nlm.nih.gov/30884194/ (accessed on 25 July 2024). [CrossRef]
- Ciprandi, G.; Cioffi, L.; Schiavetti, I.; del Giudice, M.M.; Tosca, M.A. Factors associated with wheezing recurrence in clinical practice. J. Asthma 2022, 60, 843–844. Available online: https://pubmed.ncbi.nlm.nih.gov/35666209/ (accessed on 25 July 2024). [CrossRef]
- Marseglia, G.L.; Manti, S.; Chiappini, E.; Brambilla, I.; Caffarelli, C.; Calvani, M.; Cardinale, F.; Cravidi, C.; Duse, M.; Martelli, A.; et al. Chronic cough in childhood: A systematic review for practical guidance by the Italian Society of Pediatric Allergy and Immunology. Allergol. Immunopathol. 2021, 49, 133–154. Available online: https://pubmed.ncbi.nlm.nih.gov/33641305/ (accessed on 25 July 2024). [CrossRef]
- Tozzi, A.E.; Armenio, L.; Bernardini, R.; Boner, A.; Calvani, M.; Cardinale, F.; Cavagni, G.; Dondi, A.; Duse, M.; Fiocchi, A.; et al. Pediatric allergy and immunology in Italy. Pediatr. Allergy Immunol. 2011, 22, 267–276. Available online: https://pubmed.ncbi.nlm.nih.gov/21457333/ (accessed on 25 July 2024). [CrossRef]
- Johnston, N.W.; Johnston, S.L.; Norman, G.R.; Dai, J.; Sears, M.R. The September epidemic of asthma hospitalization: School children as disease vectors. J. Allergy Clin. Immunol. 2006, 117, 557–562. [Google Scholar] [CrossRef]
- Garcia, G.; Taillé, C.; Laveneziana, P.; Bourdin, A.; Chanez, P.; Humbert, M. Anti-interleukin-5 therapy in severe asthma. Eur. Respir. Rev. 2013, 22, 251–257. Available online: https://pubmed.ncbi.nlm.nih.gov/23997052/ (accessed on 25 July 2024). [CrossRef]
- Ortega, H.G.; Liu, M.C.; Pavord, I.D.; Brusselle, G.G.; FitzGerald, J.M.; Chetta, A.; Humbert, M.; Katz, L.E.; Keene, O.N.; Yancey, S.W.; et al. Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma. N. Engl. J. Med. 2014, 371, 1198–1207. Available online: https://www.nejm.org/doi/full/10.1056/nejmoa1403290 (accessed on 25 July 2024). [CrossRef] [PubMed]
- Chupp, G.L.; Bradford, E.S.; Albers, F.C.; Bratton, D.J.; Wang-Jairaj, J.; Nelsen, L.M.; Trevor, J.L.; Magnan, A.; Ten Brinke, A. Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): A randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial. Lancet Respir. Med. 2017, 5, 390–400. Available online: https://pubmed.ncbi.nlm.nih.gov/28395936/ (accessed on 25 July 2024). [CrossRef]
- Walsh, G.M. Anti-IL-5 monoclonal antibodies for the treatment of asthma: An update. Expert. Opin. Biol. Ther. 2020, 20, 1237–1244. Available online: https://pubmed.ncbi.nlm.nih.gov/32529893/ (accessed on 25 July 2024). [CrossRef]
- Ullmann, N.; Peri, F.; Florio, O.; Porcaro, F.; Profeti, E.; Onofri, A.; Cutrera, R. Severe Pediatric Asthma Therapy: Mepolizumab. Front. Pediatr. 2022, 10, 920066. Available online: https://pubmed.ncbi.nlm.nih.gov/35844748/ (accessed on 25 July 2024). [CrossRef]
- Bousquet, J.; Heinzerling, L.; Bachert, C.; Papadopoulos, N.G.; Bousquet, P.J.; Burney, P.G.; Canonica, G.W.; Carlsen, K.H.; Cox, L.; Haahtela, T.; et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy 2012, 67, 18–24. Available online: https://pubmed.ncbi.nlm.nih.gov/22050279/ (accessed on 25 July 2024). [CrossRef]
- Ansotegui, I.J.; Melioli, G.; Walter Canonica, G.; Caraballo, L.; Villa, E.; Ebisawa, M.; Passalacqua, G.; Savi, E.; Ebo, D.; Maximiliano Gómez, R.; et al. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper. World Allergy Organ. J. 2020, 13, 100080. [Google Scholar] [CrossRef] [PubMed]
- Stanojevic, S.; Kaminsky, D.A.; Miller, M.R.; Thompson, B.; Aliverti, A.; Barjaktarevic, I.; Cooper, B.G.; Culver, B.; Derom, E.; Hall, G.L.; et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur. Respir. J. 2022, 60, 2101499. Available online: https://erj.ersjournals.com/content/60/1/2101499 (accessed on 25 July 2024). [CrossRef] [PubMed]
- Dinakar, C.; Chipps, B.E.; Matsui, E.C.; Abramson, S.L.; Irani, A.M.; Kim, J.S.; Mahr, T.A.; Pistiner, M.; Wang, J.; Katkin, J.P.; et al. Clinical tools to assess asthma control in children. Pediatrics 2017, 139, e20163438. Available online: https://pubmed.ncbi.nlm.nih.gov/28025241/ (accessed on 25 July 2024). [CrossRef] [PubMed]
- Agache, I.; Akdis, C.A.; Akdis, M.; Canonica, G.W.; Casale, T.; Chivato, T.; Corren, J.; Chu, D.K.; Del Giacco, S.; Eiwegger, T.; et al. EAACI Biologicals Guidelines—Recommendations for severe asthma. Allergy 2021, 76, 14–44. Available online: https://onlinelibrary.wiley.com/doi/full/10.1111/all.14425 (accessed on 25 July 2024). [CrossRef]
- Parisi, G.F.; Indolfi, C.; Decimo, F.; Leonardi, S.; Miraglia del Giudice, M. COVID-19 Pneumonia in Children: From Etiology to Management. Front. Pediatr. 2020, 8, 616622. Available online: https://pubmed.ncbi.nlm.nih.gov/33381482/ (accessed on 25 July 2024). [CrossRef] [PubMed]
- Cardinale, F.; Ciprandi, G.; Barberi, S.; Bernardini, R.; Caffarelli, C.; Calvani, M.; Cavagni, G.; Galli, E.; Minasi, D.; Del Giudice, M.M.; et al. Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic. Ital. J. Pediatr. 2020, 46, 84. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Diaferio, L.; Parisi, G.F.; Brindisi, G.; Indolfi, C.; Marchese, G.; Ghiglioni, D.G.; Zicari, A.M.; Marseglia, G.L.; Miraglia Del Giudice, M. Cross-sectional survey on impact of paediatric COVID-19 among Italian paediatricians: Report from the SIAIP rhino-sinusitis and conjunctivitis committee. Ital. J. Pediatr. 2020, 46, 146. Available online: https://ijponline.biomedcentral.com/articles/10.1186/s13052-020-00906-4 (accessed on 25 July 2024). [CrossRef] [PubMed]
- Aksu, K.; Demir, Ş.; Topel, M.; Yeşilkaya, S.; Ateş, H.; Koca Kalkan, İ.; Öncül, A.; Çuhadar Erçelebi, D.; Türkyilmaz, S. COVID-19 in patients with severe asthma using biological agents. Tuberk. Toraks 2021, 69, 433–436. Available online: https://pubmed.ncbi.nlm.nih.gov/34581170/ (accessed on 25 July 2024). [CrossRef] [PubMed]
- Azim, A.; Pini, L.; Khakwani, Z.; Kumar, S.; Howarth, P. Severe acute respiratory syndrome coronavirus 2 infection in those on mepolizumab therapy. Ann. Allergy Asthma Immunol. 2021, 126, 438–440. [Google Scholar] [CrossRef]
Before Treatment with Mepolizumab | After 12 Weeks of Treatment with Mepolizumab | |
---|---|---|
C-ACT | 15 | 21 |
ACQ-7 | 2, 28 | 1, 14 |
FEV 1 L (%) | 1.07 (54) | 1.69 (83) |
FEF 25% L/s (%) | 1.47 (36) | 3.02 (74) |
FEF 50% L/s (%) | 0.85 (30) | 1.79 (62) |
FEF 75% L/s (%) | 0.60 (41) | 0.90 (61) |
FeNO | 19 | 3 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Indolfi, C.; Dinardo, G.; Klain, A.; Decimo, F.; Miraglia del Giudice, M. Treatment of Severe Asthma: Case Report of Fast Action of Mepolizumab in a Patient with Recent SARS-CoV-2 Infection. Life 2024, 14, 1063. https://doi.org/10.3390/life14091063
Indolfi C, Dinardo G, Klain A, Decimo F, Miraglia del Giudice M. Treatment of Severe Asthma: Case Report of Fast Action of Mepolizumab in a Patient with Recent SARS-CoV-2 Infection. Life. 2024; 14(9):1063. https://doi.org/10.3390/life14091063
Chicago/Turabian StyleIndolfi, Cristiana, Giulio Dinardo, Angela Klain, Fabio Decimo, and Michele Miraglia del Giudice. 2024. "Treatment of Severe Asthma: Case Report of Fast Action of Mepolizumab in a Patient with Recent SARS-CoV-2 Infection" Life 14, no. 9: 1063. https://doi.org/10.3390/life14091063